A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Message: VIDEO - Valeo Pharma $VPH $VPHIF Hesperco™️ Capsules at Core of Montreal Heart Institute's Coronavirus Clinical Trial

VIDEO - Valeo Pharma $VPH $VPHIF Hesperco™️ Capsules at Core of Montreal Heart Institute's Coronavirus Clinical Trial

posted on Feb 21, 2021 07:34PM
Share
New Message
Please login to post a reply